# Cellyan Biotechnology Co., Ltd (HKPD)

> Healthcare · HK · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HKPD/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 9.44M | $ -876.1K | $ -217.9K | $ 2.27M | $ 5.14M |
| 2024 | $ 21.83M | $ 2.01M | $ 421.1K | $ 2.35M | $ 5.35M |
| 2023 | $ 7.58M | $ 269.3K | $ -146.7K | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.44 |
| Liabilities / Eq | 0.87 |
| Current Ratio | 2.93 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 3.25 |
| Gross Debt / FCF | 80.32 |

## Other views

- [Metrics](https://sponda.capital/en/HKPD.md)
- [Charts](https://sponda.capital/en/HKPD/charts.md)
- [Compare](https://sponda.capital/en/HKPD/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.